Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 164 Breast 93 Thoracic 37 Genitourinary 33 Gynecologic 28 Sarcoma 25 Head & Neck 23 CNS 19 Plasma cell 6 Lymphoid 6 Tumor-Agnostic 5 Other solid neoplasm 4 Dermatologic 3 Other hematologic neoplasm 1 Endocrine 1 Classical hematology 1

Conditions

Interventions

Cyclophosphamide 93 fludarabine phosphate 86 Busulfan 63 Cyclosporine 57 Peripheral Blood Stem Cell Transplantation 54 Mycophenolic Acid 54 Whole-Body Irradiation 53 Epoetin Alfa 53 Antilymphocyte Serum 43 fludarabine 42 Filgrastim 41 Cytarabine 41 Tacrolimus 39 Melphalan 38 Darbepoetin alfa 38 Methotrexate 34 Radiotherapy 32 Cord Blood Stem Cell Transplantation 28 Granulocyte Colony-Stimulating Factor 23 Methylprednisolone 21 Etoposide 21 apixaban 18 eltrombopag 16 Thiotepa 16 Dalteparin 16 ferric carboxymaltose 14 Daunorubicin 14 Azacitidine 14 Alemtuzumab 14 thymoglobulin 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoadjuvant Therapy × Classical hematology × Clear all

NCT00875004 2024-06-26

PLATON

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Terminated

Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡